14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for CHEK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.29 3.30 %
R2 2.27 2.27 %
R1 2.26 1.63 %
Current price: 2.22
Support S1 2.21 -0.432 %
S2 2.20 -1.07 %
S3 2.17 -2.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.75 23.87 %
R2 2.47 11.26 %
R1 2.26 1.80 %
Current price 2.22
Support S1 2.18 -1.80%
S2 2.14 -3.60%
S3 1.93 -13.06%

CHEK Predictions History

1 year ago
rocky_swisher predicted that CHEK for 2022-12-05 is going

Rank:

3 years ago
JS predicted that CHEK for 2021-02-12 is going $1.71 (-5.52%)

3 years ago
Jacob Aland predicted that CHEK for 2021-02-12 is going $5.23 (193.82%)

Rank:

3 years ago
JS predicted that CHEK for 2021-02-11 is going $1.77 (-0.56%)

3 years ago
JS predicted that CHEK for 2021-01-06 is going $1.60 (3.23%)

3 years ago
Dennis H predicted that CHEK for 2021-01-06 is going

Rank:

3 years ago
merchant predicted that CHEK for 2021-01-06 is going $2.24 (29.48%)

Rank:

3 years ago
JoeyBroemmeling predicted that CHEK for 2021-01-06 is going

Rank:

3 years ago
Curtis Lauinger predicted that CHEK for 2021-01-06 is going $2.90 (67.63%)

Rank:

3 years ago
JS predicted that CHEK for 2021-01-05 is going $1.17 (-32.37%)

Click to get the best stock tips daily for free!

About Check-Cap Ltd.

Check-Cap Ltd. Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through ... CHEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT